These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32860330)

  • 1. Adjusting oral glycopyrrolate medication for hyperhidrosis to reflect seasonal temperature variations.
    Garcia-Souto F; Del Boz J; Polo-Padillo J
    Dermatol Ther; 2020 Nov; 33(6):e14249. PubMed ID: 32860330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusting oral oxybutynin medication for hyperhidrosis to reflect seasonal temperature variations.
    Del Boz J; Millán-Cayetano JF; García-Montero P; García-Harana C; Rivas-Ruiz F; de Troya-Martín M
    Dermatol Ther; 2018 Jul; 31(4):e12615. PubMed ID: 29740900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival study of treatment adherence by patients given oral glycopyrrolate for hyperhidrosis following treatment failure with oral oxybutynin.
    Del Boz J; García-Souto F; Rivas-Ruiz F; Polo-Padillo J
    Dermatol Ther; 2020 Nov; 33(6):e14210. PubMed ID: 32827198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis.
    Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M
    Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment.
    Prouty ME; Fischer R; Liu D
    Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
    Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
    J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine.
    Walling HW
    J Am Acad Dermatol; 2012 Mar; 66(3):387-92. PubMed ID: 21820204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of the treatment of primary hyperhidrosis with oxybutynin: follow-up of 1,658 cases.
    Wolosker N; Kauffman P; de Campos JRM; Faustino CB; da Silva MFA; Teivelis MP; Puech-Leão P
    Int J Dermatol; 2020 Jun; 59(6):709-715. PubMed ID: 32301117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers.
    Del Boz J; Millán-Cayetano JF; Blázquez-Sánchez N; de Troya M
    Pediatr Dermatol; 2016 May; 33(3):327-31. PubMed ID: 27122197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
    Kumar MG; Foreman RS; Berk DR; Bayliss SJ
    Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilated pupils caused by topical glycopyrrolate for hyperhidrosis.
    Panting KJ; Alkali AS; Newman WD; Sharpe GR
    Br J Dermatol; 2008 Jan; 158(1):187-8. PubMed ID: 17944977
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary retention caused by topical glycopyrrolate for hyperhidrosis.
    Madan V; Beck MH
    Br J Dermatol; 2006 Sep; 155(3):634-5. PubMed ID: 16911300
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Puech-Leão P
    J Vasc Surg; 2012 Jun; 55(6):1696-700. PubMed ID: 22341836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mydriasis secondary to use of glycopyrrolate cream.
    Radotra A; Baneke A; Paul B
    Br J Hosp Med (Lond); 2019 Dec; 80(12):736. PubMed ID: 31822169
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy of oral anticholinergics for sympathetic overactivity in a thoracic surgery clinic.
    Hynes CF; Seevaratnam S; Gesuwan K; Margolis M; Marshall MB
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):565-8. PubMed ID: 27160942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of oral oxybutynin in the treatment of hyperhidrosis.
    Del Boz Gonzalez J; Rodríguez Barón D; Millán-Cayetano JF; de Troya Martin M
    Dermatol Ther; 2020 Nov; 33(6):e14197. PubMed ID: 32794595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
    Pariser DM; Lain EL; Mamelok RD; Drew J; Mould DR
    Clin Pharmacokinet; 2021 May; 60(5):665-676. PubMed ID: 33433785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique pattern of hyperhidrosis.
    Lewis VJ; Holt PJ
    Arch Dermatol; 2006 Feb; 142(2):264. PubMed ID: 16490867
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-life experience with oral oxybutynin long-term continuous therapy in severe hyperhidrosis and systematic review of the literature.
    Briatico G; Pampena R; Fulgione E; Babino G; Giorgio CM; D'Ambra I; Caccavale S; Longo C; Argenziano G
    Dermatol Ther; 2021 Mar; 34(2):e14832. PubMed ID: 33527699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.